Cujo what does this say (hint - try reading the whole thing) :
On 3 December, the Company was pleased to announce that Alcon, Inc (NYSE: ACL) had
FDA approval for its TRIESENCE? preservative free corticosteroid product for a range of
uses in the eye. AOS will shortly receive the US$1.0 million final milestone payment on
the product registration and expects to receive its first royalty payment in March 2008
based on sales for the partial month of December 2007. The first full quarterly royalty is
due in May 2008 for the quarter to 31 March 2008.
From the announcement dated - 17/12/2007 11:51AM 3 Company Update
- Forums
- ASX - By Stock
- asset value will be 5.7 cents post deal
AOS
advanced ocular systems limited
Cujo what does this say (hint - try reading the whole thing) :On...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review